Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125297221 | 12529722 | 1 | I | 20160622 | 20160706 | 20160706 | EXP | KR-MLMSERVICE-20160616-0321523-1 | KR-ACCORD-042052 | ACCORD | KIM EK, YOON G, KIM HS. CHEMOTHERAPY-INDUCED ENDOMETRIAL PATHOLOGY: MIMICRY OF MALIGNANCY AND VIRAL ENDOMETRITIS. AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH. 2016; 8(5):2459-2467 | 63.00 | YR | F | Y | 0.00000 | 20160706 | OT | KR | KR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125297221 | 12529722 | 1 | PS | PACLITAXEL/PACLITAXEL LIPOSOME | PACLITAXEL | 1 | U | 75436 | |||||||||||
125297221 | 12529722 | 2 | SS | CISPLATIN. | CISPLATIN | 1 | U | 0 | |||||||||||
125297221 | 12529722 | 3 | SS | IFOSFAMIDE. | IFOSFAMIDE | 1 | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125297221 | 12529722 | 1 | Cervix carcinoma |
125297221 | 12529722 | 2 | Cervix carcinoma |
125297221 | 12529722 | 3 | Cervix carcinoma |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125297221 | 12529722 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125297221 | 12529722 | Endometrial disorder | |
125297221 | 12529722 | Neutropenia | |
125297221 | 12529722 | Septic shock |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |